Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Update on Avacincaptad Pegol for Geographic Atrophy
View through CrossRef
Geographic atrophy (GA) secondary to age-related macular degeneration is the leading cause of permanent vision loss in patients over the age of 50 in developed countries. GA is characterized by the atrophy of retinal pigment epithelium and photoreceptors and can lead to central or peripheral vision loss, depending on the location of the atrophy. Currently, there are no US Food and Drug Administration-approved treatments for GA. Avacincaptad pegol (Zimura
®
; IVERIC Bio Inc, New York, NY, USA) is a C5-specific inhibitor that is being investigated as a potential treatment for GA. C5 is a key protein within the complement system, which maintains retina integrity and health under normal conditions. It is hypothesized that unregulated activation of the complement system (indicated by elevated levels of active proteins such as the membrane attack complex) can exacerbate the progression of GA. This article reviews the latest data regarding avacincaptad pegol as an investigational therapeutic for GA.
Touch Medical Media, Ltd.
Title: Update on Avacincaptad Pegol for Geographic Atrophy
Description:
Geographic atrophy (GA) secondary to age-related macular degeneration is the leading cause of permanent vision loss in patients over the age of 50 in developed countries.
GA is characterized by the atrophy of retinal pigment epithelium and photoreceptors and can lead to central or peripheral vision loss, depending on the location of the atrophy.
Currently, there are no US Food and Drug Administration-approved treatments for GA.
Avacincaptad pegol (Zimura
®
; IVERIC Bio Inc, New York, NY, USA) is a C5-specific inhibitor that is being investigated as a potential treatment for GA.
C5 is a key protein within the complement system, which maintains retina integrity and health under normal conditions.
It is hypothesized that unregulated activation of the complement system (indicated by elevated levels of active proteins such as the membrane attack complex) can exacerbate the progression of GA.
This article reviews the latest data regarding avacincaptad pegol as an investigational therapeutic for GA.
Related Results
Real-World Experience of Geographic Atrophy Treatment With Avacincaptad Pegol
Real-World Experience of Geographic Atrophy Treatment With Avacincaptad Pegol
Purpose:
To present the first real-world safety data describing the clinical experience of geographic atrophy (GA) treatment with avacincaptad pegol in a large ...
Safety and Efficacy of Damoctocog Alfa Pegol Prophylaxis in Patients with Severe Hemophilia A: Interim Results of a Post-Marketing, Interventional Study
Safety and Efficacy of Damoctocog Alfa Pegol Prophylaxis in Patients with Severe Hemophilia A: Interim Results of a Post-Marketing, Interventional Study
Abstract
Background
Damoctocog alfa pegol (BAY 94-9027, Jivi®) is an approved factor (F)VIII treatment indicated for use in previously treated patient...
Progression to complete retinal pigment epithelium and outer retinal atrophy (cRORA): post hoc analysis of the GATHER1 trial
Progression to complete retinal pigment epithelium and outer retinal atrophy (cRORA): post hoc analysis of the GATHER1 trial
Abstract
Purpose
Determine rates of progression of incomplete retinal pigment epithelium and outer retinal atrophy (iRORA...
Using Cerebrospinal Fluid Improves Detection of Individual Brain Atrophy
Using Cerebrospinal Fluid Improves Detection of Individual Brain Atrophy
Abstract
Background
Clinical neuroradiologists routinely look for expansion of CSF spaces to help identify atrophy on patient MRI scans. In contrast, automated methods for...
PO-231 Effects of exercise on muscle atrophy in simulated weightless rats
PO-231 Effects of exercise on muscle atrophy in simulated weightless rats
Objective Insufficient physical activity, aerospace weight loss, and fixed treatment of fractures, tendons, and neuropathy, or the resulting muscle atrophy caused by reduced exerci...
“Izervay (avacincaptad pegol): paving the way for vision preservation in geographic atrophy”
“Izervay (avacincaptad pegol): paving the way for vision preservation in geographic atrophy”
Age-related macular degeneration (AMD) is a progressive retinal disease that primarily affects the macula, leading to central vision loss and impaired color vision. Among its most ...
SPINAL MUSCULAR ATROPHY CLINICAL FEATURES, CLASSIFICATION, NATURAL HISTORY, GENETICS, DIAGNOSIS, COMPLICATIONS AND TREATMENT OF THE DISEASE
SPINAL MUSCULAR ATROPHY CLINICAL FEATURES, CLASSIFICATION, NATURAL HISTORY, GENETICS, DIAGNOSIS, COMPLICATIONS AND TREATMENT OF THE DISEASE
Introduction: Spinal muscular atrophy (SMA) is a complex neuromuscular disorder, it is the most usual autosomal recessively inherited lethal neuromuscular disease in pediatrics, it...
Atrophy patterns in sporadic and genetic behavioral variant frontotemporal dementia reflect brain network architecture
Atrophy patterns in sporadic and genetic behavioral variant frontotemporal dementia reflect brain network architecture
AbstractBackgroundConnections among brain regions allow pathological perturbations to spread from a single source node to multiple nodes. Patterns of neurodegeneration in multiple ...